Colin Reisner

Colin Reisner

Algemeen Directeur bij
Pearl Therapeutics, Inc.
Health Technology
Consumer Services
Commercial Services

Profiel

Colin Reisner is currently Chief Executive Officer at Pearl Therapeutics, Inc. since 2007 and a Member of the American Thoracic Society, Inc. Former positions include Executive Director-Global Respiratory Development at Novartis Corp., Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Head-Clinical Respiratory at AstraZeneca PLC, Assistant Consulting Professor at Duke University, Assistant Consulting Professor at Yale University, and Principal at Boehringer Ingelheim Corp.
Education includes undergraduate studies at the University of the Witwatersrand.

Actieve functies van Colin Reisner

BedrijvenFunctieBegin
Algemeen Directeur 01-10-2007
Corporate Officer/Principal -

Eerdere bekende functies van Colin Reisner

BedrijvenFunctieEinde
ASTRAZENECA PLC Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Colin Reisner in detail bekijken

Opleiding van Colin Reisner

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

30

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Colin Reisner